You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Harvard Business School
Merck
Moodys
AstraZeneca

Last Updated: June 1, 2020

DrugPatentWatch Database Preview

METOPROLOL TARTRATE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Metoprolol Tartrate patents expire, and when can generic versions of Metoprolol Tartrate launch?

Metoprolol Tartrate is a drug marketed by Am Regent, Baxter Hlthcare Corp, Fresenius Kabi Usa, Gland Pharma Ltd, Hikma Farmaceutica, Hospira, Luitpold, Mylan Asi, Sandoz Inc, Watson Labs, West-ward Pharms Int, Alembic Pharms Ltd, Apothecon, Aurobindo Pharma, Heritage Pharma, Ipca Labs Ltd, Mylan, Purepac Pharm, Renata, Rubicon, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Yaopharma Co Ltd, Youngtech Pharms Inc, and Sun Pharm Inds. and is included in thirty-five NDAs.

The generic ingredient in METOPROLOL TARTRATE is hydrochlorothiazide; metoprolol tartrate. There are thirty-two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; metoprolol tartrate profile page.

Drug patent expirations by year for METOPROLOL TARTRATE
Drug Prices for METOPROLOL TARTRATE

See drug prices for METOPROLOL TARTRATE

Drug Sales Revenue Trends for METOPROLOL TARTRATE

See drug sales revenues for METOPROLOL TARTRATE

Recent Clinical Trials for METOPROLOL TARTRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Qilu Hospital of Shandong UniversityN/A
Corcept TherapeuticsPhase 1
Haining Health-Coming Biotech Co., Ltd.Phase 2

See all METOPROLOL TARTRATE clinical trials

Pharmacology for METOPROLOL TARTRATE
Synonyms for METOPROLOL TARTRATE
( inverted question mark)-Metoprolol (+)-tartrate
(?)-Metoprolol (+)-tartrate
(?)-Metoprolol (+)-tartrate salt
()1-(Isopropylamino)-3-[p-(beta-methoxyethyl)phenoxy]-2-propanol (+)-tartrate salt
(+-)-1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol hemi-L-tartrate
(+-)-1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol L-(+)-tartrate (2:1) (salt)
(+-)-1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol tartrate (2:1)
(+/-)-Metoprolol (+)-tartrate salt, >=98% (titration), powder
(+/-)-Metoprolol (+)-tartrate salt, analytical standard
(2R,3R)-2,3-Dihydroxybutanedioic acid--1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol (1/2)
(2R,3R)-2,3-dihydroxybutanedioic acid;1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol
(A+/-)-Metoprolol (+)-tartrate
(y)-Metoprolol (+)-tartrate
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)-propan-2-ol 2,3-dihydroxysuccinate (2:1)
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol 2,3-dihydroxysuccinate
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol 2,3-dihydroxysuccinate (2
1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol 2,3-dihydroxysuccinate (2:1)
1-(Isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) Dextro-tartrate salt
1-(Isopropylamino)-3-(p-[beta-methoxyethyl]phenoxy)-2-propanol tartrate
1-(Isopropylamino)-3-[4-(beta-methoxyethyl)phenoxy]-2-propanol (+)-Tartrate
1-[4-(2-Methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-2-propanol hemitartrate
1-Isopropylamino-3-(p-(2-methoxyethyl)phenoxy)-2-propanol (2:1) dextro-tartrate salt
2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (2:1) (salt)
2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-, tartrate (2:1)
2-Propanol, 1-(isopropylamino)-3-(p-(2-methoxyethyl)phenoxy)-, (+-)-, tartrate (2:1)
2-Propanol, 1-[4-(2methoxyethyl)phenoxy)-3-[(1-methylethyl)amino]-, (+-)-, [R-(R*,R*)]-2,3-dihydroxy
2543AH
2C15H25NO3.C4H6O6
56392-17-7
AB2000335
AKOS015961630
AKOS016002993
AKOS025310917
ANW-58344
Apo-Metoprolol
Arbralene
AS-10163
Azumetop
BCP12837
Beloc
Beprolo
Bloksan
Bloxan
Cardoxone
CAS-56392-17-7
CCG-220733
CCG-222032
CGP 2175E
CGP-2175E
CHEBI:6906
CHEMBL2062335
CHEMBL3186768
CTK8B7746
D00601
DB-052906
DSSTox_CID_17248
DSSTox_GSID_37248
DSSTox_RID_79315
DTXSID9037248
EINECS 260-148-9
EU-0100728
H 93/26
HMS1570C08
HMS2097C08
HMS3262A18
HMS3651I21
HMS3714C08
Jeprolol
Kapodine
KS-00000XQB
Lanoc
Lopac-M-5391
LS-122402
M 5391
M2555
Mepolol
Meto AbZ
Meto-Isis
Metoberag
Metoberta
Metocard
Metolol
Metomerck
Metop
Metoproferm
Metoprolin
Metoprolol acis
Metoprolol AL
Metoprolol Apogepha
Metoprolol Atid
Metoprolol Basics
Metoprolol hemitartrate
Metoprolol Heumann
Metoprolol PB
Metoprolol Stada
Metoprolol tartrate (2:1)
Metoprolol tartrate (JP17/USP)
Metoprolol Tartrate [USAN:JAN]
Metoprolol tartrate [USAN:USP:JAN]
Metoprolol Tartrate 1.0 mg/ml in Methanol (as free base)
Metoprolol tartrate solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Metoprolol tartrate, British Pharmacopoeia (BP) Reference Standard
Metoprolol tartrate, European Pharmacopoeia (EP) Reference Standard
Metoprolol Tartrate, Pharmaceutical Secondary Standard; Certified Reference Material
Metoprolol tartrate, United States Pharmacopeia (USP) Reference Standard
Metoprolol Verla
Metoprolol-(+,-) (+)-tartrate salt
Metoprolol-GRY
Metoprolol-radiopharm
Metoprolol-rpm
metoprolol-tartrate
Metoprolol-Wolf
MFCD00056257
Minax
NCGC00016170-01
NCGC00017119-01
NCGC00021148-08
NCGC00094074-01
NCGC00094074-02
NCGC00261413-01
PMS-Metroprolol-B
Prelis
Prestwick_1009
Proken M
Prolaken
Q-201402
Q27292351
rac Metoprolol Hemi (+)-Tartrate
Ritmolol
RTR-019802
SCHEMBL1649321
SCHEMBL2051655
Selectadril
Selokeen
Selopral
Sigaprolol
Slow lopresor
Slow-Lopresor
SR-01000872674
SR-01000872674-1
ST24037610
SW199199-2
Topromel
Tox21_110787
Tox21_110787_1
Tox21_113528
Tox21_500728
Vasocardin

US Patents and Regulatory Information for METOPROLOL TARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rubicon METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 200981-005 Aug 21, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 073666-002 Dec 21, 1993 DISCN No No   Start Trial   Start Trial   Start Trial
Teva METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 074143-001 Sep 30, 1994 DISCN No No   Start Trial   Start Trial   Start Trial
Alembic Pharms Ltd METOPROLOL TARTRATE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; metoprolol tartrate TABLET;ORAL 202870-001 Nov 6, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Harvard Business School
Merck
Moodys
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.